Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens
about
Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system.Neural stem cell niches in health and diseasesPeripherally-derived BDNF promotes regeneration of ascending sensory neurons after spinal cord injuryLupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosusDevelopment of protective autoimmunity by immunization with a neural-derived peptide is ineffective in severe spinal cord injury.Advances in regenerative therapies for spinal cord injury: a biomaterials approach.Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation.Immunization with neural derived peptides plus scar removal induces a permissive microenvironment, and improves locomotor recovery after chronic spinal cord injuryTherapeutic vaccination for central nervous system repair.Boosting controlled autoimmunity: a new therapeutic target for CNS disorders.Role of myelin-associated inhibitors in axonal repair after spinal cord injury.Cross-talk between neural stem cells and immune cells: the key to better brain repair?Taking a bite out of spinal cord injury: do dental stem cells have the teeth for it?Sexual dimorphism in the spontaneous recovery from spinal cord injury: a gender gap in beneficial autoimmunity?Low-dose gamma-irradiation promotes survival of injured neurons in the central nervous system via homeostasis-driven proliferation of T cells.Toll-like receptor-4 knockout mice are more resistant to optic nerve crush damage than wild-type mice.
P2860
Q24539880-BBC794B1-5F40-46A0-BE96-0C5D30F95F70Q26995185-18CAC0C7-9A84-4EC5-8BB1-3CC946A7BECFQ27301855-3FF590EE-5A09-4028-9BD4-B90C181E64D6Q28268802-20A5B63D-3934-41BD-B156-782C33643DD7Q34163814-548FC929-0E9E-4CA0-B289-8CBDCAC9572CQ35746310-8E08B7BB-BACA-4176-80B4-214EB609211AQ36066082-A2387E00-4FAE-4C7F-BB87-4EE379C36DC4Q36240711-B368EA10-F21D-4CE2-8C8C-DDD7BC7D8450Q36478853-7995203D-854C-4740-B9C0-8DF4A1B8867CQ37154818-78716C18-1EB0-4017-825F-CFCCC93E3EA6Q37877302-2AABFFFA-87AB-4364-8A14-99C4FEE59B29Q38029969-0099F0B1-B2D3-4C1B-94B5-6B0B1ED31747Q38697049-B5FFD41C-3348-430A-B9BA-907113C333A1Q44216018-D4A5A604-524F-40E5-BF85-1F7C97C0B30BQ44796520-9C8962DD-D548-47A4-AE94-4C85C4C4E85CQ53585154-40A66324-83BE-4563-A80E-824DE06223B9
P2860
Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Vaccination with a Nogo-A-deri ...... son with other myelin antigens
@ast
Vaccination with a Nogo-A-deri ...... son with other myelin antigens
@en
type
label
Vaccination with a Nogo-A-deri ...... son with other myelin antigens
@ast
Vaccination with a Nogo-A-deri ...... son with other myelin antigens
@en
prefLabel
Vaccination with a Nogo-A-deri ...... son with other myelin antigens
@ast
Vaccination with a Nogo-A-deri ...... son with other myelin antigens
@en
P2093
P2860
P356
P1476
Vaccination with a Nogo-A-deri ...... son with other myelin antigens
@en
P2093
P2860
P304
15173-15178
P356
10.1073/PNAS.011585298
P407
P50
P577
2001-12-01T00:00:00Z